Your browser doesn't support javascript.
loading
Cardiovascular and Renal Outcomes With Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors Combination Therapy: A Meta-Analysis of Randomized Cardiovascular Outcome Trials.
Singh, Awadhesh Kumar; Singh, Akriti; Singh, Ritu.
Affiliation
  • Singh AK; G. D. Hospital and Diabetes Institute, Kolkata, West Bengal, India; Sun Valley Hospital and Diabetes Research Center, Guwahati, Assam, India; Horizon Life Line Multispecialty Hospital, Kolkata, West Bengal, India. Electronic address: drawadheshkumarsingh@gmail.com.
  • Singh A; Jawaharlal Nehru Medical College and Hospital, Kalyani, West Bengal, India.
  • Singh R; G. D. Hospital and Diabetes Institute, Kolkata, West Bengal, India; Horizon Life Line Multispecialty Hospital, Kolkata, West Bengal, India.
Endocr Pract ; 29(7): 509-516, 2023 Jul.
Article in En | MEDLINE | ID: mdl-37037286

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Endocr Pract Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Sodium-Glucose Transporter 2 Inhibitors / Heart Failure Type of study: Clinical_trials / Systematic_reviews Limits: Humans Language: En Journal: Endocr Pract Journal subject: ENDOCRINOLOGIA Year: 2023 Document type: Article Country of publication: Estados Unidos